Cineverse Q2 revenue misses expectations

Cineverse

14/11/2025 21:18

Overview

Cineverse Q2 FY 2026 revenue declined 3% yr/yr, missing analyst expectations

Company's direct operating margin improved by 7% over prior-year quarter

Outlook

Cineverse plans to reissue Pan's Labyrinth in late 2026

Company expects The Toxic Avenger Unrated to generate over 40% IRR

Cineverse advancing MicroCo venture with Banyan Ventures

Result Drivers

REVENUE TIMING - Revenue decline attributed to timing differences in content licensing agreements

MARGIN IMPROVEMENT - Direct operating margin improved by 7% over prior-year quarter

MARKETING COSTS - Increased SG&A expenses due to marketing costs for 'The Toxic Avenger Unrated' and investments in theatrical slate

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$12.36 mln
$12.66 mln (2 Analysts)
Q2 EPS
-$0.31
Q2 Net Income
-$5.55 mln
Q2 Operating Expenses
$17.77 mln
Q2 Operating Income
-$5.41 mln
Q2 Pretax Profit
-$5.53 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the entertainment production peer group is "buy"

Wall Street's median 12-month price target for Cineverse Corp is $8.00, about 68.3% above its November 13 closing price of $2.54

Press Release: ID:nPn5MjDwSa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)